Literature DB >> 16902215

Ulcerative colitis: diagnosis and management.

Paul Collins1, Jonathan Rhodes.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16902215      PMCID： PMC1539087          DOI： 10.1136/bmj.333.7563.340

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  22 in total

1.  Colorectal cancer prevention in ulcerative colitis: a case-control study.

Authors:  J Eaden; K Abrams; A Ekbom; E Jackson; J Mayberry
Journal:  Aliment Pharmacol Ther       Date:  2000-02       Impact factor: 8.171

2.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 3.  Inflammatory bowel disease: new insights into pathogenesis and treatment.

Authors:  S Ardizzone; G Bianchi Porro
Journal:  J Intern Med       Date:  2002-12       Impact factor: 8.989

4.  The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.

Authors:  A G Fraser; T R Orchard; D P Jewell
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.

Authors:  R D Cohen; D M Woseth; R A Thisted; S B Hanauer
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

6.  The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.

Authors:  A G Fraser; D Morton; D McGovern; S Travis; D P Jewell
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

Review 7.  Ciclosporin and refractory colitis.

Authors:  A Barney Hawthorne
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-03       Impact factor: 2.566

Review 8.  Management of inflammatory bowel disease.

Authors:  M Nayar; J M Rhodes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

9.  Studies on the mechanism of bowel disturbance in ulcerative colitis.

Authors:  S S Rao; N W Read; C Brown; C Bruce; C D Holdsworth
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

10.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059
View more
  19 in total

1.  Avoid delaying surgery in patients with severe ulcerative colitis.

Authors:  Neil J Smart
Journal:  BMJ       Date:  2006-09-02

Review 2.  Autologous bone marrow stem cell transplantation for the treatment of ulcerative colitis complicated with herpes zoster: a case report.

Authors:  Hang Xiang; Xiaomei Zhang; Chao Yang; Wenhuan Xu; Xin Ge; Rong Zhang; Ya Qiu; Wanjun Sun; Fan Li; Tianyuan Xiang; Haixu Chen; Zheng Wang; Qiang Zeng
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

3.  Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.

Authors:  Emily A Minor; Justin T Kupec; Andrew J Nickerson; Karthikeyan Narayanan; Vazhaikkurichi M Rajendran
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

4.  MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients.

Authors:  Beytullah Yıldırım; Candan Tuncer; Derya Kan; Bilge Tunc; Mehmet Derya Demirag; E Ferda Percın; Seminur Haznedaroglu; Hakan Alagozlu
Journal:  Rheumatol Int       Date:  2010-03-12       Impact factor: 2.631

5.  Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran.

Authors:  Salaheddin Vaji; Zivar Salehi; Keyvan Aminian
Journal:  Int J Colorectal Dis       Date:  2010-07-29       Impact factor: 2.571

6.  Identification of diagnostic signatures in ulcerative colitis patients via bioinformatic analysis integrated with machine learning.

Authors:  Jiajie Lu; Zhiyuan Wang; Munila Maimaiti; Wenjia Hui; Adilai Abudourexiti; Feng Gao
Journal:  Hum Cell       Date:  2021-11-03       Impact factor: 4.174

Review 7.  Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis.

Authors:  Morris Gordon; Vassiliki Sinopoulou; Anthony K Akobeng; Mirela Pana; Rehab Gasiea; Gordon William Moran
Journal:  Cochrane Database Syst Rev       Date:  2022-04-07

8.  Epidemiology and gene markers of ulcerative colitis in the Chinese.

Authors:  Jun Yun; Chang-Tai Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

9.  Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).

Authors:  Harald Matthes; Thomas Krummenerl; Manfred Giensch; Corinna Wolff; Jürgen Schulze
Journal:  BMC Complement Altern Med       Date:  2010-04-15       Impact factor: 3.659

10.  Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control study.

Authors:  Sally A Stapley; Greg P Rubin; Deborah Alsina; Elizabeth A Shephard; Matthew D Rutter; William T Hamilton
Journal:  Br J Gen Pract       Date:  2017-03-27       Impact factor: 5.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.